Explore GRIN2D/GluN2D gene products and cross-species
research data at TarMart platform. Discover comprehensive
biological information, expression tools, and therapeutic
insights for Homo sapiens (human), Cynomolgus monkeys, rodents
(mouse/rat), canines, felines, bovines, and equines. Your
premier destination for multi-species gene research solutions
Target
sublocation: Transmembrane Protein.
N-methyl-D-aspartate (NMDA) receptors are a class of ionotropic glutamate receptors. NMDA channel has been shown to be involved in long-term potentiation, an activity-dependent increase in the efficiency of synaptic transmission thought to underlie certain kinds of memory and learning. NMDA receptor channels are heteromers composed of the key receptor subunit NMDAR1 (GRIN1) and 1 or more of the 4 NMDAR2 subunits: NMDAR2A (GRIN2A), NMDAR2B (GRIN2B), NMDAR2C (GRIN2C), and NMDAR2D (GRIN2D). [provided by RefSeq, Mar 2010]
| Target ID |
GM-T56588
|
| Target Name |
GRIN2D/GluN2D
|
Gene Group ldentifer
（Target Gene ID in Homo
species)
|
2906
|
| Gene ID |
101095061 (Felis catus), 102148904 (Equus caballus), 14814 (Mus musculus), 24412 (Rattus norvegicus)
2906 (Homo sapiens), 484405 (Canis lupus familiaris), 618181 (Bos taurus), 717945 (Macaca mulatta)
|
| Target Alternative Names |
DEE46,EB11,EIEE46,GRIN2D,GluN2D,Glutamate [NMDA] receptor subunit epsilon-4,Glutamate receptor ionotropic,Grin2d,N-methyl D-aspartate receptor subtype 2D (NMDAR2D,NMDA 2D,NMDAR2D,NR2D,NR2D)
|
| Uniprot Accession |
Q03391,Q62645,O15399
|
| Uniprot Entry Name |
|
| Protein Sub-location |
Transmembrane Protein
|
| Category |
Therapeutics Target
|
| Disease |
|
| Disease from KEGG |
Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Cocaine addiction, Amphetamine addiction, Nicotine addiction
|
| Gene Ensembl |
ENSECAG00000037147, ENSMUSG00000002771, ENSG00000105464, ENSCAFG00845001419, ENSBTAG00000023369, ENSMMUG00000005983
|
| Target Classification |
|
GRIN2D/GluN2D siRNA/miRNA/oligo for RNA interfence (RNAi)
| Cat No. | Product Name | GeneID | Species | Grade | Detail |
|---|
| pGMoligo2906 | Pre-made Human GRIN2D/EB11/NR2D siRNA oligo Duplex | 2906 | Human | In-vitro grade; in-vivo grade | Detail |
| pGMoligo24412 | Pre-made Rat Grin2d/GluN2D siRNA oligo Duplex | 24412 | Rat | In-vitro grade; in-vivo grade | Detail |
| pGMoligo14814 | Pre-made Mouse Grin2d/NR2D/GluN2D siRNA oligo Duplex | 14814 | Mouse | In-vitro grade; in-vivo grade | Detail |
| pGMoligo717945 | Pre-made Cynomolgus/Rhesus macaque GRIN2D siRNA oligo Duplex | 717945 | Cynomolgus/Rhesus macaque | In-vitro grade; in-vivo grade | Detail |
| pGMoligo101095061 | Pre-made Cat/Feline GRIN2D siRNA oligo Duplex | 101095061 | Cat/Feline | In-vitro grade; in-vivo grade | Detail |
| pGMoligo484405 | Pre-made Dog/Canine GRIN2D siRNA oligo Duplex | 484405 | Dog/Canine | In-vitro grade; in-vivo grade | Detail |
| pGMoligo618181 | Pre-made Bovines/Cattle GRIN2D siRNA oligo Duplex | 618181 | Bovines/Cattle | In-vitro grade; in-vivo grade | Detail |
| pGMoligo102148904 | Pre-made Equine/Horse GRIN2D siRNA oligo Duplex | 102148904 | Equine/Horse | In-vitro grade; in-vivo grade | Detail |
GRIN2D/GluN2D antibody/GMab
| Cat No. | Species | Antibody Name | Format | Classified by tag | Detail |
|---|
| GM-Tg-hg-T56588-Ab | Human | Anti-Human GRIN2D/GluN2D monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-rg-T56588-Ab | Rat | Anti-Rat GRIN2D/GluN2D monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-mg-T56588-Ab | Mouse | Anti-Mouse GRIN2D/GluN2D monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cynog-T56588-Ab | Cynomolgus/Rhesus macaque | Anti-Cynomolgus/Rhesus macaque GRIN2D/GluN2D monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-felg-T56588-Ab | Cat/Feline | Anti-Cat/Feline GRIN2D/GluN2D monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cang-T56588-Ab | Dog/Canine | Anti-Dog/Canine GRIN2D/GluN2D monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-bovg-T56588-Ab | Bovines/Cattle | Anti-Bovines/Cattle GRIN2D/GluN2D monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-equg-T56588-Ab | Equine/Horse | Anti-Equine/Horse GRIN2D/GluN2D monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
GRIN2D/GluN2D VLP (virus-like particle)
| Cat No. | Species | Antigen Name | Expression Platform | Detail |
|---|
| GM-Tg-hg-T56588-Ag | Human | Human GRIN2D/GluN2D VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-rg-T56588-Ag | Rat | Rat GRIN2D/GluN2D VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-mg-T56588-Ag | Mouse | Mouse GRIN2D/GluN2D VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cynog-T56588-Ag | Cynomolgus/Rhesus macaque | Cynomolgus/Rhesus macaque GRIN2D/GluN2D VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-felg-T56588-Ag | Cat/Feline | Cat/Feline GRIN2D/GluN2D VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cang-T56588-Ag | Dog/Canine | Dog/Canine GRIN2D/GluN2D VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-bovg-T56588-Ag | Bovines/Cattle | Bovines/Cattle GRIN2D/GluN2D VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-equg-T56588-Ag | Equine/Horse | Equine/Horse GRIN2D/GluN2D VLP (virus-like particle) | HEK293 | Products Developing |
